Successful response to vismodegib therapy in locally advanced basal cell carcinoma with orbital involvement: A case report

Background: Basal cell carcinoma (BCC) is the most common skin cancer, often treated surgically. However, surgery may pose a high functional risk in cases of advanced orbital structures. Vismodegib, a hedgehog pathway inhibitor, is approved for locally advanced or metastatic BCC unfit for surgery o...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mateo Aguirre-Flórez, Mauricio Arias-Flórez, Valeria López-Pulgarín, Mariana Alexandra Herrera-Caicedo, Daniel Millán-Morales
Formato:	Artigo
Idioma:	Espanhol
Publicado em:	Universidad Ricardo Palma 2026-03-01
coleção:	Revista de la Facultad de Medicina Humana
Assuntos:	Basal cell carcinoma vismodegib hedgehog signaling pathway eyelid neoplasms
Acesso em linha:	https://urp-upgrade.metarevistas.org/index.php/RFMH/article/view/7354
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!